2022
Treatment outcomes of HIV patients with hepatitis B and C virus co-infections in Southwest China: an observational cohort study
Jia J, Zhu Q, Deng L, Lan G, Johnson A, Chen H, Shen Z, Li J, Xing H, Ruan Y, Li J, Lu H, Vermund SH, Zhu J, Qian HZ. Treatment outcomes of HIV patients with hepatitis B and C virus co-infections in Southwest China: an observational cohort study. Infectious Diseases Of Poverty 2022, 11: 7. PMID: 34986877, PMCID: PMC8734096, DOI: 10.1186/s40249-021-00921-5.Peer-Reviewed Original ResearchConceptsHepatitis B virusHepatitis C virusAntiretroviral therapyHigh mortalityHCV coinfectionC virusNational Free Antiretroviral Treatment ProgramHBV co-infected patientsHBV/HCV coinfectionRetrospective cohort study analysisEffect of ARTCohort study analysisObservational cohort studyAntiretroviral treatment programOverall mortality rateProportional hazards modelTreatment attrition rateCause deathHCV-coHIV patientsBaseline infectionCohort studyHBV-HCVHepatitis BHepatitis treatment
2010
An Empirical Approach to Defining Loss to Follow-up Among Patients Enrolled in Antiretroviral Treatment Programs
Chi BH, Cantrell RA, Mwango A, Westfall AO, Mutale W, Limbada M, Mulenga LB, Vermund SH, Stringer JS. An Empirical Approach to Defining Loss to Follow-up Among Patients Enrolled in Antiretroviral Treatment Programs. American Journal Of Epidemiology 2010, 171: 924-931. PMID: 20219765, PMCID: PMC2850972, DOI: 10.1093/aje/kwq008.Peer-Reviewed Original ResearchConceptsAntiretroviral therapyHIV-infected adultsAntiretroviral treatment programLTFU definitionTreatment cohortsPatient attritionLast appointmentPatient lossCohort membersLTFUConsensus criteriaTreatment programPatientsOne-thirdMore reliable comparisonsDaysAppointmentsTherapyCohortCliniciansMisclassificationMarginal differencesVisitsCare
2004
Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy
Reid SE, Reid CA, Vermund SH. Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy. International Journal Of STD & AIDS 2004, 15: 713-716. PMID: 15537453, DOI: 10.1258/0956462042395195.Peer-Reviewed Original ResearchConceptsAntiretroviral therapyInfected personsAntiretroviral treatment programAntiretroviral drug therapyHuman immunodeficiency virusResource-limited settingsAdherence strategiesImmunodeficiency virusSaharan AfricaAdequate adherenceDrug therapyDrug costsLeprosy controlTreatment programTherapyTuberculosisLeprosyAdherenceControl programs